Dr. Luc Duchesne

About Dr. Luc Duchesne

Dr. Luc C. Duchesne is a Speaker and Author with a PhD in Biochemistry. With three decades of scientific and business experience, he has published 85 scientific papers, and has recently published his first novel, "The Moose Motel: A Tale of Golden Revenge". The Founder and CEO for GSN DreamWorks Inc. based in Ottawa, Luc is a regular columnist for InvestorIntel.

199 InvestorIntel Articles By Dr. Luc Duchesne


Cannabis bubble, THC cloud, and alternate reality

January 22, 2018
| January 22, 2018 | 2 Comments

Publically traded Canadian cannabis companies are doing exceptionally well. Common shares of Canopy Growth Corporation (WEED), the biggest cannabis company […]

National Defense Authorization Act bolsters strategic mineral miners

December 22, 2017
| December 22, 2017 | 3 Comments

Strategic minerals miners are contemplating a bright future in the wake of the signing of the 2018 National Defense Authorization […]

Para fuels gold expansion plans by scoring (another) near-term production asset

December 05, 2017
| December 05, 2017

Earlier today, Para Resources Inc. (TSXV: PBR) (“Para”) announces that it has (yet) again, taken advantage of current market conditions to acquire […]

Leading the race in the wonder material world of graphene

December 04, 2017
| December 04, 2017

Australian technology minerals company, Talga Resources Ltd. (“Talga”) (ASX: TLG), announced promising initial test results from epoxy resin-based coatings formulated […]

Tapping a periodic table of possibilities for all industrial sectors through data sensing automation

October 31, 2017
| October 31, 2017

Augusta Industries Inc. (TSXV: AAO) (“Augusta”) is engaged in the development, design, manufacture and supply of systems using fiber optic […]

Carbon Dioxide Delivery Technology Provides BlueOcean Market Advantage

October 31, 2017
| October 31, 2017

BlueOcean NutraSciences Inc. (TSXV: BOC) (“BlueOcean”) announced that it is shifting focus toward carbon dioxide (CO2) grow-solutions gas infusion business to […]